Enhanced nicotine-seeking behavior following pre-exposure to repeated cocaine is accompanied by changes in BDNF in the nucleus accumbens of rats


Autoria(s): Leão, Rodrigo M.; Cruz, Fábio C.; Carneiro-De-Oliveira, Paulo E.; Rossetto, Daniella B.; Valentini, Sandro Roberto; Zanelli, Cleslei Fernando; Planeta, Cleopatra da Silva
Contribuinte(s)

Universidade Estadual Paulista (UNESP)

Data(s)

27/05/2014

27/05/2014

01/03/2013

Resumo

We investigated the behavioral and molecular interactions between cocaine and nicotine, through evaluating locomotor activity, nicotine intravenous self-administration and gene expression. Locomotor sensitization was induced in male Wistar rats by repeated cocaine (20 mg/kg; i.p.) or saline injections once a day over 7 days. Three days after the last injection, rats were challenged with either saline or cocaine (15 mg/kg; i.p.) and the locomotor activity was measured. The very next day animals received either saline or nicotine (0.4 mg/kg; s.c.) and the locomotor cross-sensitization was tested. Animals were then prepared with intrajugular catheters for nicotine self-administration. Nicotine self-administration patterns were evaluated using fixed or progressive ratio schedules of reinforcement and a 24-h unlimited access binge. Immediately after the binge sessions animals were decapitated, the brains were removed and the nucleus accumbens was dissected. The dynorphin (DYN), μ-opioid receptor (mu opioid), neuropeptide Y (NPY), brain-derived neurotrophic factor (BDNF), tropomyosin-related tyrosine kinase B receptor (TrkB) and corticotropin- releasing factor receptor type 1 (CRF-R1) gene expression were measured by the reverse transcription-polymerase chain reaction (RT-PCR). Pretreatment with cocaine caused sensitization of cocaine motor response and locomotor cross-sensitization with nicotine. In the self-administration experiments repeated cocaine administration caused an increase in the nicotine break point and nicotine intake during a 24 h binge session. © 2013 Elsevier Inc.

Formato

169-176

Identificador

http://dx.doi.org/10.1016/j.pbb.2013.01.007

Pharmacology Biochemistry and Behavior, v. 104, n. 1, p. 169-176, 2013.

0091-3057

1873-5177

http://hdl.handle.net/11449/74684

10.1016/j.pbb.2013.01.007

WOS:000316594400022

2-s2.0-84874155130

2-s2.0-84874155130.pdf

Idioma(s)

eng

Relação

Pharmacology Biochemistry and Behavior

Direitos

openAccess

Palavras-Chave #BDNF #Cocaine #Gene expression #Locomotor activity #Nicotine #RT-PCR #Self-administration #brain derived neurotrophic factor #brain derived neurotrophic factor receptor #cocaine #corticotropin releasing factor #dynorphin #mu opiate receptor #nicotine #sodium chloride #animal experiment #animal model #animal tissue #brain tissue #controlled study #cross allergy #decapitation #drug seeking behavior #gene expression #locomotion #male #nonhuman #nucleus accumbens #priority journal #rat #reinforcement #reverse transcription polymerase chain reaction #Animals #Brain-Derived Neurotrophic Factor #Dynorphins #Gene Expression #Male #Motor Activity #Neuropeptide Y #Nucleus Accumbens #Rats #Rats, Wistar #Receptor, trkB #Receptors, Corticotropin-Releasing Hormone #Receptors, Opioid, mu #Risk Factors #Self Administration #Tobacco Use Disorder #Animalia #Rattus #Rattus norvegicus
Tipo

info:eu-repo/semantics/article